A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study

Condition:   Graves' Orbitopathy Interventions:   Drug: Atorvastatin 20mg;   Other: Placebo Sponsors:   University of Pisa;   Università degli Studi dell'Insubria;   University of Catania;   University of Messina Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials